TITLE

THE TRUE RISK OF BARRETT'S OESOPHAGUS--HAS IT BEEN UNDERESTIMATED?

AUTHOR(S)
Kelty, C. J.; Gough, M. D.; van Wyk, Q.; Stephenson, T. J.; Ackroyd, R.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA59
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Barrett's oesophagus (BO) is the major risk factor for adenocarcinoma of the oesophagus, which is increasing in incidence more rapidly than any other cancer in the Western world. The risk of developing carcinoma in BO has been expressed in a number of different ways, for example from 30-125 times increased risk, 1 in 52 to 1 in 441 patient years of follow up, 0.5-1% per year, and 10-15% lifetime risk. However, much of this is based upon historical data, and the criteria for making the diagnosis have become more stringent since many of these studies were published, although recent guidelines, by the British Society of Gastroenterology, do not require intestinal metaplasia to be present for the diagnosis. It has been shown that the intestinal metaplasia is required for the diagnosis of BO, and that this phenotype carries malignant potential.
ACCESSION #
13219043

 

Related Articles

  • The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only-what is the clinical significance? Meining, A.; Ott, R.; Becker, I.; Hahn, S.; Mühlen, J.; Werner, M.; Höfler, H.; Classen, M.; Heidwein, W.; Rösch, T. // Gut;Oct2004, Vol. 53 Issue 10, p1402 

    Background: The incidence of distal oesophageal adenocarcinoma is rising, with chronic reflux and Barrett's oesophagus being considered risk factors. Reliable detection of Barrett's oesophagus during upper endoscopy is therefore mandatory but requires both endoscopy and histology for...

  • Utilization of Cytokeratins 7 and 20 Does Not Differentiate between Barrett’s Esophagus and Gastric Cardiac Intestinal Metaplasia. Mohammed, I. A.; Streutker, C. J.; Riddell, R. H. // Modern Pathology;Jun2002, Vol. 15 Issue 6, p611 

    Long segment Barrett's esophagus (LSBE) is a recognized risk factor for the development of esophageal dysplasia and carcinoma. However, the risk of dysplasia arising within intestinal metaplasia below a normal-appearing Z-line (i.e., in native cardiac mucosa) is unknown. Regular endoscopic...

  • Risk of adenocarcinoma in Barrett's oesophagus: population based study. Gavin, Anna; Murray, Liam; Watson, Peter; Johnston, Brian; Sloan, James; Lal Mainie, Inder Mohan // BMJ: British Medical Journal (International Edition);9/6/2003, Vol. 327 Issue 7414, p534 

    This article investigates the risk of oesophageal malignancy in a large cohort of unselected patients with Barrett's oesophagus in Northern Ireland, where all incident cancers are routinely identified. We identified patients in the cohort and followed them up for death and oesophageal...

  • Laparoscopic treatment of Barrett’s esophagus: long-term results. Biertho, L.; Dallemagne, B.; Dewandre, J.-M.; Jehaes, C.; Markiewicz, S.; Monami, B.; Wahlen, C.; Weerts, J. // Surgical Endoscopy;Jan2007, Vol. 21 Issue 1, p11 

    Gastroesophageal reflux disease (GERD) is considered the main etiologic process in the metaplastic development of Barrett’s esophagus (BE). The most serious complication of BE is the possible dysplastic evolution to esophageal carcinoma. Many treatments have been described to prevent the...

  • Factors Influencing The Development of Barrett's Epithelium in The Esophageal Remnant Postesophagectomy. O'Riordan, J. M.; Tucker, O. N.; Byrne, P. J.; McDonald, G. S. A.; Ravi, N.; Keeling, P. W. N.; Reynolds, J. V. // American Journal of Gastroenterology;Feb2004, Vol. 99 Issue 2, p205 

    BACKGROUND: Barrett's esophagus results from chronic reflux of both acid and bile. Reflux of gastric and duodenal contents is facilitated through the denervated stomach following esophagectomy, but the development of Barrett's changes in this model and the relationship to gastric and esophageal...

  • Biomarker Studies in Reversed Barrett's Esophagus. Garewal, Harinder; Ramsey, Lois; Sharma, Prateek; Kraus, Kevin; Sampliner, Richard; Fass, Ronnie // American Journal of Gastroenterology;Oct1999, Vol. 94 Issue 10, p2829 

    OBJECTIVE: The purpose of this study was to use biomarkers to assess for cancer risk in Barrett's esophagus patients with either squamous islands or complete reversal of their intestinal metaplasia to squamous epithelium. METHODS: The biomarkers included proliferation characteristic using Ki-67,...

  • Understanding Barrett's oesophagus, part 1: Surveillance and management. Bailey, Karen // Gastrointestinal Nursing;Oct2009, Vol. 7 Issue 8, p28 

    Barrett's oesophagus is a condition that can predispose patients to the development of oesophageal cancer. Surveillance for this condition has the potential to detect early changes, although the value of endoscopic surveillance is debated. In the first of three articles exploring Barrett's...

  • Hand Necrosis Resulting from Cannulation Injury of the Radial Artery. Giuliani, Andrea; Scimò, Michele; Costi, Umberto; Basso, Luigi // American Surgeon;Dec2013, Vol. 79 Issue 12, p1310 

    The article discusses the case of an 82-year-old male patient with distal esophageal cancer who developed acute hand ischemia following a cannulation injury of the radial artery. Information on his medical history is provided, as well as details of the surgical procedure. Also discussed are the...

  • OESOPHAGEAL ADENOCARCINOMA: A VERY BRITISH DISEASE. Misra, N.; Hardwick, R. H. // Gut;Apr2004 Supplement 3, Vol. 53, pA60 

    The focus of this article is to investigate which geographical areas have the highest incidence rates of oesophageal adenocarcinoma in the world. Incidence data for oesophageal adenocarcinoma were retrieved from the Cancer in Five Continents Volume VIII database, a database comprising incidence...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics